Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares OutstandingShort-Term Debt repayments
Ratios

China Pharma Holdings (CPHI) Short-Term Debt issuances (2016 - 2023)

Historic Short-Term Debt issuances for China Pharma Holdings (CPHI) over the last 4 years, with Q4 2023 value amounting to $1.0 million.

  • China Pharma Holdings' Short-Term Debt issuances changed N/A to $1.0 million in Q4 2023 from the same period last year, while for Dec 2024 it was $1.0 million, marking a year-over-year decrease of 3295.75%. This contributed to the annual value of $492761.0 for FY2024, which is 6784.85% down from last year.
  • Latest data reveals that China Pharma Holdings reported Short-Term Debt issuances of $1.0 million as of Q4 2023.
  • Over the past 5 years, China Pharma Holdings' Short-Term Debt issuances peaked at $3.0 million during Q3 2021, and registered a low of -$6171.0 during Q3 2023.
  • Over the past 3 years, China Pharma Holdings' median Short-Term Debt issuances value was $336052.0 (recorded in 2020), while the average stood at $690606.6.
  • The largest annual percentage gain for China Pharma Holdings' Short-Term Debt issuances in the last 5 years was 29266.28% (2021), contrasted with its biggest fall of 9267.61% (2021).
  • Over the past 3 years, China Pharma Holdings' Short-Term Debt issuances (Quarter) stood at $160979.0 in 2020, then plummeted by 92.68% to $11790.0 in 2021, then surged by 8667.42% to $1.0 million in 2023.
  • Its Short-Term Debt issuances stands at $1.0 million for Q4 2023, versus -$6171.0 for Q3 2023 and -$6011.0 for Q2 2023.